Funding will be targeted at antimicrobials, oncology and other unmet needs
The charity LifeArc – formerly a branch of the Medical Research Council known as MRC Technology – had pledged to invest £500 million over the next five years to support key areas of biomedical research including antimicrobials, neuroscience, personalised oncology and respiratory medicine.